Presentation GI2 2012 Drug-Eluting Balloon: Clinical Evidence for In-Stent Restenosis Presenter: Marco V. Wainstein April 12, 2012 REGISTER for free or LOG IN to view this content DES/BRS/DCB Presentation GI2 2012 Up Next Presentation Clopidogrel Discontinuation After Myocardial Infarction and Risk of Thrombosis Presenter: Mette Charlot July 19, 2012 More slides + Presentation Incidence, Predictors, and Implications of Access Site Complications with Transfemoral TAVR Presenter: Nicolas M. Van Mieghem July 27, 2012 Presentation Phase II Study Assessing the Efficacy, Safety of Variable Anticoagulation Reversal with REG1 in ACS Presenter: 78830|Thomas Povsic August 09, 2012 We Recommend
Presentation Clopidogrel Discontinuation After Myocardial Infarction and Risk of Thrombosis Presenter: Mette Charlot July 19, 2012
Presentation Incidence, Predictors, and Implications of Access Site Complications with Transfemoral TAVR Presenter: Nicolas M. Van Mieghem July 27, 2012
Presentation Phase II Study Assessing the Efficacy, Safety of Variable Anticoagulation Reversal with REG1 in ACS Presenter: 78830|Thomas Povsic August 09, 2012